MedPath

The effect of hypertonic glucose infusion on dialysis outcomes and quality of life in non-diabetic patients undergoing hemodialysis

Phase 3
Conditions
Hemodialysis Patients.
Cloudy (hemodialysis) (peritoneal) dialysis effluent
R88.0
Registration Number
IRCT20121229011923N8
Lead Sponsor
Shoushtar Faculty of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
106
Inclusion Criteria

Hemodialysis for at least 6 months
Lack of other chronic illnesses that lead to disability and have a direct impact on dialysis adequacy (such as severe heart disease, respiratory disease, motor movement disorders, malignant diseases, liver failure).

Exclusion Criteria

Acute complications during the study period such as heart and lung resuscitation or hospitalization
Unwillingness to continue participating in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath